Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Cullinan Therapeutics Inc’s stock clocked out at $16.71, down -1.18% from its previous closing price of $16.91. In other words, the price has decreased by -$1.18 from its previous closing price. On the day, 0.63 million shares were traded. CGEM stock price reached its highest trading level at $17.1 during the session, while it also had its lowest trading level at $16.2163.
Ratios:
To gain a deeper understanding of CGEM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.87 and its Current Ratio is at 28.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 01, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $30.Wedbush initiated its Outperform rating on February 15, 2024, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 05 ’24 when Michaelson Jennifer sold 8,000 shares for $16.33 per share. The transaction valued at 130,640 led to the insider holds 123,942 shares of the business.
Michaelson Jennifer sold 58,000 shares of CGEM for $1,628,159 on May 06 ’24. The Chief Scientific Officer now owns 129,582 shares after completing the transaction at $28.07 per share. On May 07 ’24, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 5,606 shares for $30.06 each. As a result, the insider received 168,516 and left with 129,582 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 968788928 and an Enterprise Value of 309028672.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is -8.67%, while the 200-Day Moving Average is calculated to be 2.76%.
Shares Statistics:
It appears that CGEM traded 824.42K shares on average per day over the past three months and 741430 shares per day over the past ten days. A total of 42.90M shares are outstanding, with a floating share count of 38.41M. Insiders hold about 30.56% of the company’s shares, while institutions hold 77.54% stake in the company. Shares short for CGEM as of 1722384000 were 8355333 with a Short Ratio of 10.13, compared to 1719532800 on 7836514. Therefore, it implies a Short% of Shares Outstanding of 8355333 and a Short% of Float of 16.72.
